via University of Oxford
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms.
A University of Oxford study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, outlines a new type of blood test that can be used to detect a range of cancers and whether these cancers have spread (metastasised) in the body.
The study analysed samples from 300 patients with non-specific but concerning symptoms of cancer, such as fatigue and weight loss, who were recruited through the Oxfordshire Suspected CANcer (SCAN) pathway.
The researchers assessed whether the test could distinguish patients with a range of solid tumours from those without cancer. Their results show that cancer was correctly detected in 19 out of every 20 patients with cancer using this test. In those with cancer, metastatic disease was identified with an overall accuracy of 94%. These results make this the first technology to be able to determine the metastatic status of a cancer from a simple blood test, without prior knowledge of the primary cancer type.
This test shows promise to help clinicians detect cancer and assess cancer stage in the future. Unlike many blood-based tests for cancer, which detect genetic material from tumours, this test uses a technique called NMR metabolomics, which uses high magnetic fields and radio waves to profile levels of natural chemicals (metabolites) in the blood.
Healthy individuals, people with localised cancer, and people with metastatic cancer each have different profiles of blood metabolites, which can be detected and then analysed by the researchers’ algorithms to distinguish between these states.
Dr James Larkin, researcher on the study from the University of Oxford, says: ‘Cancer cells have unique metabolomic fingerprints due to their different metabolic processes. We are only now starting to understand how metabolites produced by tumours can be used as biomarkers to accurately detect cancer. We have already demonstrated that this technology can successfully identify if patients with multiple sclerosis are progressing to the later stages of disease, even before trained clinicians could tell. It is very exciting that the same technology is now showing promise in other diseases, like cancer.’
Cancers detected earlier are more likely to be treated successfully. This rapid and inexpensive test could help to overcome many barriers to the early detection of cancer, especially in patients that present with non-specific symptoms, which do not direct investigations towards a specific organ. NHS Rapid Diagnostic Centres, similar to Oxfordshire’s SCAN pathway, are currently being set up across the NHS to support faster and earlier cancer diagnosis in all patients with symptoms that could indicate cancer.
This new test is not specific to a single cancer type and has shown promise in this traditionally challenging clinical context, including the potential to detect some cancers in the community before conventional imaging is performed.
Dr Fay Probert, lead researcher of the study from the University of Oxford, says: ‘This work describes a new way of identifying cancer. The goal is to produce a test for cancer that any GP can request. We envisage that metabolomic analysis of the blood will allow accurate, timely and cost-effective triaging of patients with suspected cancer, and could allow better prioritisation of patients based on the additional early information this test provides on their disease.’
Future studies with larger patient cohorts will further evaluate this technique for the earlier detection of new cancers and potential clinical applications.
Original Article: New test can identify if a patient has cancer and if it has spread
More from: University of Oxford
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cancer blood test
- More young women are getting breast cancer. So an expert panel recommends this change
More:New blood test under development by Lilly and Roche could make diagnosing Alzheimer's easier Women may want to start getting screened earlier because cancer in younger people tends to be more ...
- The FDA Will Test You Now
The agency makes a power grab to regulate lab tests like medical devices.
- Cancer Supertests Are Here
Multi-cancer-screening tools—or “ cancer-finding supertests ,” as Galleri has been called— aren’t yet endorsed by the U.S. Preventive Services Task Force, or formally approved by the Food and Drug ...
- Could blood tests make early stage cancer diagnosis accessible?
A U.S. company is developing a blood test to detect 18 types of cancers. But there is still work ahead to prove its value.
- Artificial intelligence could help diagnose cancer with one spot of dried blood
Scientists in China have created a test using artificial intelligence that can detect cancer using one spot of dried blood.
Go deeper with Google Headlines on:
Cancer blood test
[google_news title=”” keyword=”cancer blood test” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Metabolomic fingerprints
- Best Fingerprint Sensor Phones (April 2024) in India
Fingerprint sensors, for example, have progressed to being embedded beneath the display; we've listed some of the best smartphones with in-display fingerprint sensors that unlock quickly.
- Fact-check: Can hackers steal fingerprints from selfies?
The clip claims fraudsters can use the images to take high-quality copies of their fingerprints, which they then use to hack into their phones and accounts to steal their money and data.
- Nick Saban’s fingerprints will be all over another NFL Draft
One day the Nick Saban era of Alabama football is going to end. Totally and completely. Unofficially as well as officially. That day is not today. Today Saban will wear two hats as the NFL Draft ...
- God’s Fingerprints: The Trinity is Everywhere
We can see the trinity of space and the trinity of time as what might be called God’s fingerprints on his handiwork. For the atheist, however, who refuses to accept the existence of God and who ...
- A molecular fingerprint beyond the Nyquist frequency
More information: Hanieh Fattahi et al, Compressed Sensing of Field-resolved Molecular Fingerprint Beyond the Nyquist Frequency, Ultrafast Science (2024). DOI: 10.34133/ultrafastscience.
Go deeper with Google Headlines on:
Metabolomic fingerprints
[google_news title=”” keyword=”metabolomic fingerprints” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]